JANUX THERAPEUTICS INC (JANX) Stock Balance Sheet
NASDAQ:JANX - Nasdaq - US47103J1051 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 73.74M | N/A | 19.20M | 51.40M | 35.60M | |||
| Marketable Securities | 940.40M | N/A | 324.82M | 275.60M | 339.40M | |||
| Receivables | 5.58M | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 3.61M | 8.49M | 5.21M | 5.40M | 2.10M | |||
| Total Current Assets | 1.02B | 1.03B | 349.00M | 332.40M | 377.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 23.82M | 24.00M | 28.00M | 29.40M | 1.60M | |||
| Other Non-Current Assets | 3.61M | 2.88M | 2.51M | 2.20M | 1.20M | |||
| Total Non-Current Assets | 27.43M | 28.00M | 31.00M | 31.60M | 2.80M | |||
| TOTAL ASSETS | 1.05B | 1.06B | 380.00M | 364.00M | 379.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 15.15M | 13.00M | 8.88M | 8.80M | 4.00M | |||
| Accounts Payable | 2.35M | 4.03M | 2.42M | 2.20M | 2.50M | |||
| Other Current Liabilities | N/A | 0.00 | 1.73M | 5.60M | 6.40M | |||
| Total Current Liabilities | 17.50M | 17.00M | 13.00M | 16.50M | 12.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.80M | 21.00M | 23.00M | 26.80M | 700.00K | |||
| Total Non-Current Liabilities | 20.80M | 22.00M | 23.00M | 26.80M | 700.00K | |||
| TOTAL LIABILITIES | 38.30M | 39.00M | 36.00M | 43.30M | 13.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -261.26M | -238.00M | -169.00M | -110.50M | -47.40M | |||
| Additional Paid In Capital | 1.27B | 1.26B | 512.00M | 432.70M | 414.00M | |||
| Common Shares | 59.00K | 60.00K | 50.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 3.76M | 2.16M | 670.00K | -1.50M | -300.00K | |||
| Shares Outstanding | 59.17M | 59.00M | 46.00M | 41.60M | 41.60M | |||
| Tangible Book Value per Share | 17.11 | N/A | 7.45 | 7.71 | 8.81 | |||
| Total Shareholders' Equity | 1.01B | 1.02B | 344.00M | 320.70M | 366.30M | |||
| TOTAL LIABILITIES AND EQUITY | 1.05B | 1.06B | 380.00M | 364.00M | 379.80M | |||
| Statistics | ||||||||
| Current Ratio | 58.47 | 60.82 | 26.85 | 20.15 | 29.45 | |||
| Return On Assets (ROA) | -7.40% | -6.50% | -15.34% | -17.32% | -8.60% | |||
| Return On Equity (ROE) | -7.68% | -6.74% | -16.95% | -19.66% | -8.92% | |||
All data in USD , ROIC based on taxRate of 0.21